Radical Surgical Resection

PROCEDURE2 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions

Biliary Tract CancerHNSCC

Phase 2

Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Not yet recruitingNCT07778732

Tianjin Medical University Cancer Institute and HospitalHNSCC

Start: 2026-09-01End: 2028-09-01Target: 32Updated: 2026-08-21

Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally Advanced Biliary Tract Cancer

RecruitingNCT07797816

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolBiliary Tract Cancer

Start: 2026-01-08End: 2028-12-31Target: 31Updated: 2026-09-01